Get the Stockscreener App
0.385
6.10%
-0.025
After Hours:
1.06
0.675
+175.32%
Biotricity Inc stock is traded at $0.385, with a volume of 59,775.
It is down -6.10% in the last 24 hours and down -36.44% over the past month.
See More
Previous Close:
$0.41
Open:
$0.3819
24h Volume:
59,775
Relative Volume:
51.73
Market Cap:
$N/A
Revenue:
$11.63M
Net Income/Loss:
$-14.58M
P/E Ratio:
-0.2199
EPS:
-1.751
Net Cash Flow:
$-7.41M
1W Performance:
-6.10%
1M Performance:
-36.44%
6M Performance:
-42.72%
1Y Performance:
-79.83%
1-Day Range:
$0.36
$0.3951
1-Week Range:
$0.36
$0.3951
52-Week Range:
$0.36
$0.41
Biotricity Inc Stock (BTCY) Company Profile
Compare BTCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.93 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.65 | 833.82M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.82 | 120.57M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.152 | 320.01M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.63 | 0 | 0 | 0 | 0 | 0.00 |
Biotricity Inc Stock (BTCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-22 | Initiated | Lake Street | Buy |
| Nov-23-21 | Initiated | H.C. Wainwright | Buy |
Biotricity Inc Stock (BTCY) Latest News
Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022 - ACCESS Newswire
Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance
Q1 Earnings Forecast for Biotricity Issued By HC Wainwright - Defense World
H.C. Wainwright maintains Neutral rating on Biotricity stock despite growth By Investing.com - Investing.com Canada
Biotricity Inc Reports Q4 2025 Earnings: Revenue Growth and Strategic Partnerships Drive Progress - AInvest
Biotricity Inc (BTCY) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Biotricity Inc (BTCY) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships Propel Progress - GuruFocus
Biotricity Inc (BTCY) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Biotricity (OTCMKTS:BTCY) Trading 2.1% Higher – What’s Next? - Defense World
Biotricity Delivers Strong Fiscal Year 2025 Results with - GlobeNewswire
Biotricity's Q4 Earnings: A Glimpse into the Future of Remote Cardiac Monitoring - AInvest
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach | BTCY Stock News - GuruFocus
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue - GuruFocus
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach - The Globe and Mail
Biotricity Inc. Expands Cardiac Monitoring Solutions - TipRanks
Biotricity (BTCY.US) will release its Earnings Reports after the market closes on July 18. - 富途牛牛
Biotricity to Report Fiscal 2025 Q4 Financial Results on July 18th - AInvest
Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th - GlobeNewswire
BIOTRICITY INC. SEC 10-K Report - TradingView
Healthcare Tech Breakthrough: Biotricity Hits First-Ever Positive EBITDA, Reports Record Financial Performance - Stock Titan
Wearable Pregnancy Devices Market Set to Witness Significant - openPR.com
Rogue Funds’ New Holding: Biotricity (BTCY) - Insider Monkey
Biotricity Inc. Delays Yearly Report Filing - The Globe and Mail
Biotricity (BTCY) Expected to Announce Earnings on Wednesday - Defense World
Analyzing Biotricity (NASDAQ:BTCY) and Stryker (NYSE:SYK) - Defense World
Biotricity (NASDAQ:BTCY) Shares Down 10.5% – Here’s Why - Defense World
Biotricity (OTCMKTS:BTCY) Stock Price Down 5.2% – Here’s What Happened - Defense World
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Comparing Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) - Defense World
VOO ETF News, 4/8/2025 - The Globe and Mail
Biotricity Recognized by Financial Times as One of 2025’s - GlobeNewswire
Healthcare Tech Leader Biotricity's Massive 256% Growth Lands Coveted FT Recognition - Stock Titan
Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30 - ACCESS Newswire
Biotricity to Present at LD Micro Invitational Investor Conference on June 7, 2016 - ACCESS Newswire
Biotricity (NASDAQ:BTCY) & Accuray (NASDAQ:ARAY) Financial Review - The AM Reporter
Holter Monitoring Systems Market Future Business - openPR.com
Biotricity Expands IP Portfolio With More Than a Dozen New Patents - Medical Product Outsourcing
Biotricity (OTC: BTCY) Expands IP Portfolio with 14 New Patents - drpjournal.com
Biotricity Announces Patient Filing for Cutting-Edge Biotres Device - ACCESS Newswire
Shares Of This Micro Cap Rally On IP Expansion News - The Globe and Mail
Biotricity expands IP portfolio with 14 new patents - TipRanks
Biotricity Expands IP Portfolio & Strategy with 14 New - GlobeNewswire
14 New Patents Power Biotricity's Game-Changing Watch-to-Patch Medical Monitor - StockTitan
Head to Head Contrast: DexCom (NASDAQ:DXCM) vs. Biotricity (NASDAQ:BTCY) - Defense World
Holter Monitoring Systems Market Growth in Future Scope - openPR
Reviewing Alphatec (NASDAQ:ATEC) and Biotricity (NASDAQ:BTCY) - Defense World
Biotricity Completes Nasdaq Listing - ACCESS Newswire
Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023 - ACCESS Newswire
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd - ACCESS Newswire
Biotricity Inc (BTCY) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion Amidst Challenges - GuruFocus.com
Biotricity Inc Stock (BTCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.17%
Cap:
|
Volume (24h):